ATOSSA THERAPEUTICS INC
For the period ended Sep 30, 2024. Filed Nov 12, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 12, 2024
ATOS$2.13+0.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
EXHIBIT INDEX
| Incorporated by Reference Herein or Filed or Furnished Herewith | |||
| ExhibitNo. | Description | Form | Date |
| 10.1# | Employment Agreement with Heather Rees Dated July 1, 2024 | Quarterly Report on Form 10-Q as Exhibit 10.2# | August 12, 2024 |
| 31.1 | Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act | Filed herewith | |
| 31.2 | Certification Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act | Filed herewith | |
| 32.1 | Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act | Furnished herewith | |
| 32.2 | Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act | Furnished herewith | |
| 101.INS | Inline XBRL Instance Document | ||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document With Embedded Linkbase Documents | ||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL and contained in Exhibit 101) | ||
#Indicates management contract or compensatory plan, contract or agreement.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.